• Flanders Investment & Trade
  • Team Vesalius

Emeritus professor Marleen Temmerman made history as Belgium's first woman professor of gynecology

Marleen Temmerman


Sint-Pietersnieuwstraat 25
9000 Ghent

She is associated with UGent, one of Flanders’ five universities, and is considered a figurehead for women’s health and rights. She held several leading positions in international women’s and health organizations, such as the World Health Organization's Department of Reproductive Health and Research.

In 2015, she joined the Aga Khan Development Network in Kenya and became Director, Centre of Excellence in Women, Adolescents and Child Health at the Aga Khan University. Temmerman has received high critical acclaim for her work. The Marleen Temmerman Fund, which originated from Ghent University, supports the projects of the International Center for Reproductive Health (ICRH) Global and its sister organisations in Belgium, Mozambique and Kenya. All of them have been committed to women's rights and women's health for more than 25 years.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?